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Abstract 
Free intracellular calcium ([Ca2+]i), in addition to being an important second 
messenger, is a key regulator of many cellular processes including the cell 
membrane potential, proliferation and apoptosis.  In many cases, the mobilization of 
[Ca2+]i is controlled by intracellular store activation and calcium influx. We have 
investigated the effect of several ion channel modulators, which have been used to 
treat a range of human diseases, on [Ca2+]i release, by ratiometric calcium imaging. 
We show that six such modulators (Amiodarone (Ami), Dofetilide (Dof), Furosemide 
(Fur), Minoxidil (Min), Loxapine (Lox), and Nicorandil (Nic)) initiate release of [Ca2+]i 
in prostate and breast cancer cell lines, PC3 and MCF7, respectively. Whole cell 
currents in PC3 cells were inhibited by the compounds tested in patch clamp 
experiments in a concentration dependent manner. In all cases [Ca2+]i was increased 
by modulator concentrations comparable to those used clinically.  The increase in 
[Ca2+]i in response to Ami, Fur, Lox and Min was reduced, significantly (p<0.01), 
when the external calcium was reduced to nM concentration by chelation with EGTA. 
The data suggest that many ion channel regulators mobilize [Ca2+]i. We suggest a 
mechanism whereby calcium induced calcium release is implicated; such a 
mechanism may be important for understanding the action of these compounds. 
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Introduction 
A number of ion channel modulators are used for the treatment of diseases ranging 
from cardiac arrhythmia to psychosis (Delisle et al., 2004). Although many 
modulators have been studied for their pharmacological properties, surprisingly little 
information is available on the role they may play in the availability of free 
intracellular calcium ([Ca2+]i). Free intracellular calcium availability is critical for cell 
function (e.g. proliferation, apoptosis, gene regulation)(Berridge et al., 2000). [Ca2+]i 
also acts as an intracellular transducer for extracellularly activated signalling (e.g. the 
Wnt signalling pathway (Thrasivoulou et al., 2013)). [Ca2+]i release due to the action 
of commonly used drugs in different cell types may provide clues regarding some 
side effects of these compounds. For example, antihypertensive drugs lower the 
levels of [Ca2+]i in erythrocytes (Baumgart et al., 1986). Epidemiological studies 
indicate that patients on anti-hypertensive drugs have a lower incidence of cancer 
progression and mortality for breast, skin and prostate cancers (Barron et al., 2011; 
Lemeshow et al., 2011; Melhem-Bertrandt et al., 2011; Grytli et al., 2013).  
In this work, we decided to concentrate on six commonly used clinical compounds, 
namely, Amiodarone (Ami), Dofetilide (Dof), Furosemide (Fur), Minoxidil (Min), 
Loxapine (Lox) and Nicorandil (Nic) to investigate their role in [Ca2+]i release in 
prostate and breast cancer cells. These drugs act as anti-hypertensives, anti-
arrhythmic, vasodilator and diuretic, by modulating ion channels and transporters.  
 
We performed a series of experiments to investigate the role of these modulators as 
inhibitors of cellular pathways. By using electrophysiology and live cell calcium 
imaging we discovered that Ami, Dof, Fur, Min, Lox and Nic alter whole cell currents 
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and activate [Ca2+]i stores in cancer cells (PC3, prostate cancer cell line and MCF7, 
breast cancer cell line). Most of these compounds increase [Ca2+]i release with 
distinct kinetics via calcium induced calcium release (CICR) (Bootman et al., 2002) 
dependent and independent mechanisms. Our results reveal a novel mechanism of 
action of numerous ion channel modulators that have the potential of manipulating 
the magnitude and duration of free [Ca2+]i changes in mammalian cells in vitro. 
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Materials and Methods 
Compounds 
Stock solutions were prepared in phosphate buffered saline (PBS, without Ca2+ or 
Mg2+ pH 7.4  catalog no. 10010, Gibco™). All compounds used in live [Ca2+]i 
experiments (Amiodarone hydrochloride, Dofetilide, Furosemide, Minoxidil, Loxapine 
succinate salt and Nicorandil) were purchased from Sigma-Aldrich and dissolved in 
Dimethyl sulfoxide (DMSO) ReagentPlus®, (Sigma-Aldrich). Systematic names of 
the compounds are: Amiodarone hydrochloride: 2-Butyl-3-benzofuranyl)[4-[2-
(diethylamino)ethoxy]-3,5-diiodophenyl]methanone hydrochloride; Dofetilide: N-[4-[2-
[Methyl[2-[4-
[(methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]methanesulfonamide; 
Furosemide: 4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid; Minoxidil: 6-(1-
Piperidinyl)-2,4-pyrimidinediamine 3-oxide; Loxapine succinate salt: 2-Chloro-11-(4-
methyl-1-piperazinyl)dibenzo[b,f][1,4]oxazepine  and 1,4-Butanedioic acid; 
Nicorandil: 2-(Pyridine-3-carbonylamino)ethyl nitrate (also see Supplemental 
information for structures). 
 
Cell Culturing 
The cell lines used (PC3, prostate cancer and MCF7, breast cancer) were obtained 
from ATCC. The protocols used to culture these have been described elsewhere 
(Thrasivoulou et al., 2013). Briefly, cells were cultured in RPMI Medium 1640 
(Gibco™) supplemented with 5mM L-glutamine and fetal bovine serum (FBS) (10%).  
Dissociated cells were plated in filtered, 25cm2 NuncTM EasYFlaskTM (Thermo 
  JPET #236695 
8 
 
Scientific) at a plating density of 105 cells/flask. Dissociation of cells was achieved by 
treating the cells for 3 minutes with 1ml of Trypsin (2.5%)/Versene (ratio 1:9, 
Gibco™) incubated at 37 °C. Cells were maintained at 37 °C in a humidified 5% CO2 
atmosphere and 21% O2. 
 
High Throughput Electrophysiology 
Experiments were performed using the QPatch single-hole and QPatch multi-hole 
technologies with QPlate (Biolin-Sophion). The QPlate contains 16 or 48 individual 
patch-clamp sites that are operated asynchronously and in parallel. PC3 were 
cultured and harvested using Detachin and kept in the QStirrer (Biolin-Sophion) on 
the QPatch prior to the automatic preparation. The intracellular (IC) solution 
contained (in mM concentrations): CaCl2 5.3, MgCl2 1.7, EGTA 10; HEPES 10; KCl 
120 and Na2-ATP 4; pH 7.2 with osmolarity of 295 mOsm. The IC is thus calculated 
to contain 680 nM free calcium. The extracellular (EC) solution contained CaCl2 2, 
MgCl2 1, HEPES 10, KCl 4 and NaCl 145; pH 7.4 with osmolarity adjusted to 285-
295 mOsm. 
Subsequent to the cell suspension being transferred from the QStirrer to the QPlate, 
a pressure of -70 mBar was applied to obtain positioning and sealing of the cells. A 
whole cell protocol with pressure pulses at -150 mBar was used to obtain whole cell 
formation. Thereafter the membrane was clamped at -90 mV between execution of 
the voltage protocols. 
 
IC solutions and compounds are applied by eight pipettes. PC3 cells were kept in 
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culture medium in the QStirrer for up to four hours. Prior to testing, the cells were 
transferred to the QFuge (Biolin-Sophion), spun down and washed in Ringer’s 
solution twice before being applied to the measuring site in the QPlate. Gigaseals 
were formed upon execution of a combined suction/voltage protocol. Further suction 
lead to establishment of the whole-cell configuration. Solutions and compounds were 
applied through the glass-coated flow channels in the QPlate. Currents were 
recorded using a command ramp from -120 to +120 mV at 0.5mV/ms every 3 sec. 
Data were sampled at 5kHz and filtered using a 4th order Bessel filter.  
The IC50 values were calculated using a Hill equation fit to the average currents (Ic)in 
a single experiment as the concentrations were increased. Thus  
Ic =  Ib+(If-Ib)*((c/iec50)h/(1+(c/iec50)h)) 
where Ib and If is the baseline and final  response current levels, respectively, iec50 
is the IC50 or EC50 value, h is the Hill coefficient and c is the compound 
concentration. A Levenberg-Marquardt minimization was used to fit the parameters. 
 
Intracellular Calcium Imaging 
[Ca2+]i imaging was performed as described elsewhere (Thrasivoulou et al., 2013). 
Cells were grown as a monolayer in 35mm FluoroDish (WPI) in 3ml of culture 
medium for 60-80h prior to imaging. Fluorescent Ca2+ indicators FuraRed and Fluo-4 
(Invitrogen) were loaded in the FluoroDish 30 min before imaging and incubated at 
37°C. Both fluorescent indicators were added at 1μg/ml (~1.3 μM) after removing 2 
out of 3 ml of medium in the FluoroDish. Prior to imaging, the FluoroDish was 
washed with PBS (2x) and replaced with 1ml of fresh PBS. Live [Ca2+]i imaging was 
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performed on an Olympus FluoView 1000 confocal microscope using a 20× dry 
objective (NA 0.75) at 37 °C. Fluorescent Ca2+ indicators were excited with an argon 
laser line (488 nm), and emissions were recorded in the green channel (500–560 
nm) for Fluo-4 and red channel (600–700 nm) for FuraRed. Image and data 
acquisition was performed using FluoView 1000 software (Olympus). Fluorescent 
intensity was measured and data exported as a tab delimited file and in an Excel file 
format for further analysis using Wolfram Mathematica 10.3 (Supplemental Figure 1), 
MedCalc (v 13.1.2) and OriginPro 2015 (OriginLab) software.  
 
Free Calcium Measurements in Solutions 
Since imaging experiments were carried out in nominally zero calcium solutions, 
calcium ion measurements were made using a B-751 LAQUAtwin Compact Calcium 
Ion Meter (Horiba), calibrated using standard calcium solutions (provided by the 
manufacturer) in “one-point calibration in low concentration” mode. The experiments 
were repeated with different batches of solutions over different days. When chelated 
by EGTA, free calcium was reduced to <10 nM at 37oC. 
 
Data Analysis and Statistics  
The kinetics of free [Ca2+]i (e.g. time constants for rise, dwell and fall times) were 
calculated using analysis described previously (Thrasivoulou et al., 2013). Briefly, 
from the baseline of the signal to the highest point of the peak, two parallel lines are 
placed on the 10% and 90% (y-axis) of the peak. This creates four interception 
points on the waveform. Rise time (RT) is defined as the time from the first point to 
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the second; Dwell time (DT) similarly from the second to the third and Fall time (FT) 
from the third to the fourth. The data acquired from the FuraRed and Fluo-4 
channels, were exported from the FluoView 1000 software and the Fluo-4/FuraRed 
ratio calculated. Fluo-4 is not fluorescent unless bound to Ca2+ and used as an 
indicator for free intracellular calcium; FuraRed fluorescence decreases once bound 
to Ca2+.  The two indicators have reciprocal shifts in intensity due to calcium binding 
and are used together in a ratiometric probe strategy. The time-series data was then 
plotted using Origin 2015 software (OriginLab Corp.) and used as the basis for 
measurements on the kinetics of calcium mobilization. The rise, dwell and fall times 
were calculated as described elsewhere (Wang et al., 2010; Thrasivoulou et al., 
2013). Statistical analysis was performed using Mann-Whitney U test using software 
MedCalc v15.8. Wolfram Mathematica 10.3 (used for Supplemental Figure 1) was 
programmed to analyse the data automatically, for some experiments, using the 
same methods for the peak analysis and time constant calculations as used with 
Origin. 
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Results 
Electrophysiological properties of compounds on whole cell currents in PC3 cells 
The electropharmacology of a number of compounds has been described with IC50 
concentrations in micromolar range for the modulation of endogenous currents, 
largely for anti-arrhythmic function in cardiac cells (Leblanc et al., 1989; Rasmussen 
et al., 1992; Satoh, 1993; Kodama et al., 1997; Desai et al., 2000; Thummler et al., 
2007b; Biton et al., 2012) but also some other cell types (Desai et al., 2000) 
including cell lines over-expressing specific ion channel proteins (Thummler et al., 
2007b) (summarized in Supplemental Table 1). We first established a concentration 
dependence for the inhibition of endogenous currents in PC3 cells using a multi-
patch system (QPatch, see Material and Methods) using five different concentrations 
of the compounds. 
Fig 1 shows currents at a range of potentials elicited in whole cell clamped PC3 cells 
using a ramp command potential (from -120 to +120mV). All compounds inhibited 
whole cell endogenous currents in PC3 cells by 25-70%. The mean inward current at 
-100mV was inhibited by 69% by 33µM Loxapine (n=5), by 57% by 50 µM Dofetilide 
(n=4), by 30% by 50µM Minoxidil (n=3) and by 61% by 50µM Nicorandil (n=3). At 
positive potentials (e.g. +100mV) the inhibition of the whole cell current was relatively 
less (between 24 to 50%). The results indicate that there exists an inhibitable inward 
movement of cations at more negative potentials. 
The data show no indication of a pronounced voltage dependence to the inhibition. 
To establish the concentration dependence of inhibition, the endogenous currents 
were measured at +120 mV (Fig. 2) and at -70 mV. The IC50 for the six compounds 
used ranged between 10-300µM. These results indicate that endogenous currents in 
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PC3 cells are modulated by the six compounds tested. Based upon these 
experiments we used 50µM as the concentration for most of the compounds tested 
for [Ca2+]i release experiments.  
 
[Ca2+]i release in response to ion channel activity modulating compounds 
Addition of the tested compounds to the extracellular solution caused a change in 
the ratio of Fluo-4/FuraRed in PC3 cells (Fig. 3 and representative Supplemental 
movies SM1-SM6). When the ratio of Fluo-4/FuraRed was plotted against time, the 
free [Ca2+]i rise induced by all compounds can be described as having a distinct rise 
from the baseline, dwelling in the plateau phase and return to  back to the baseline 
(Fig. 4). This waveform was used to measure the amplitude and kinetics of the 
activation of [Ca2+]i in PC3 cells in response to Amiodarone, Dofetilide, Furosemide, 
Minoxidil, Loxapine and Nicorandil. The amplitude of calcium signal varied between 
the compounds with Minoxidil, Amiodarone and Loxapine demonstrating the highest 
amplitude and Furosemide, Nicorandil and Dofetilide relatively low amplitude (Fig. 5). 
The amplitude of calcium release in PC3 cells for Ami, Dof, Fur, Lox, Min and Nic 
were 2 ± 0.2, 1 ± 0.1, 1.2 ± 0.1, 1.5 ± 0.2, 1.7 ± 0.2 and 1.2 ± 0.1 (mean ± SEM, n= 
30-78 cells from 4-10 individual experiments), respectively relative to a baseline of 
1.0. The [Ca2+]i release in response to these compounds was also concentration-
dependent (Fig. 6). In addition, all compounds induced a [Ca2+]i rise  in MCF7 cells, a 
breast cancer cell line  (Supplemental Figure 2 and Supplemental movies SM7-
SM12). Thus the phenomenon was not specific to the PC3 cell line only. 
We have previously observed that DMSO (dimethyl sulfoxide), the vehicle used to 
dissolve organic compounds such as Thapsigargin (Thastrup et al., 1990) or those 
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used in this study, can induce [Ca2+]i release in PC3 cells (Thrasivoulou et al., 2013) 
in addition to other cell types (Morley and Whitfield, 1993). This was the case here 
(Fig. 4 and Supplemental Figure 2). To limit the contamination of the [Ca2+]i signal by 
the effects of DMSO two strategies were adopted:   
1. The [Ca2+]i release by experimental compound dissolved in DMSO was 
investigated in the same cell following exposure to DMSO alone (similar to 
(Thrasivoulou et al., 2013) and (Morley and Whitfield, 1993)). When this control was 
used, there was a relatively small [Ca2+]i release after exposure to DMSO alone (e.g. 
Amiodarone, Supplemental Figure 3).  
2. Ethanol and methanol were used as the solvent instead of DMSO. For example, 
when Loxapine or Furosemide were dissolved in ethanol or methanol (Supplemental 
Figures 4 and 5), the [Ca2+]i release was similar to that observed when these 
compounds were resuspended in DMSO. Such controls indicate that [Ca2+]i release 
is induced by the compounds with minimal, if any, contribution from the effects of 
DMSO and that the DMSO induced [Ca2+]i occurs by a different mechanism than 
those induced by the compounds used in this study.  
 
Kinetics of [Ca2+]i release: Rise, dwell and fall time 
The waveform was characterized by three constants: rise time (the time needed to 
reach maximum amplitude), dwell time (the time the signal stays at the peak) and fall 
time (the time needed for the signal to fall from peak back to baseline), according to 
criteria described previously (Thrasivoulou et al., 2013). The time constants indicate 
that the [Ca2+]i release characteristics varied significantly between the compounds 
  JPET #236695 
15 
 
tested (Fig. 7 A-C). For example, the free [Ca2+]i release by Dofetilide demonstrates 
a relatively low amplitude and long duration (Fig. 4, 6 and 7B). Minoxidil and 
Dofetilide displayed the slowest rise and fall time, as well as the longest dwell time 
(Fig. 7 A-C). A principal component analysis of the compounds based upon the dwell 
time characteristics of [Ca2+]i showed that these drugs showed three components 
with most drugs segregating into two components (Fig. 7D). These results indicate 
that Minoxidil and Dofetilide induce a slow exhaustion and replenishments of the free 
[Ca2+]i stores. Dofetilide had the slowest rise, dwell and fall time.   
 
The characteristics of rise time, dwell time and fall time seemed to follow a specific 
pattern for any given compound, e.g. a reagent that has a fast rise time, would also 
have a short dwell time and fast fall time or vice versa. Nicorandil, unlike the other 
compounds used is an activator of K+ channels (Kukovetz et al., 1992). The [Ca2+]i 
waveform for Nicorandil was relatively small and similar to that of DMSO, both in 
amplitude and duration (Fig. 4 and Fig. 7B). In some experiments, Nicorandil 
induced [Ca2+]i release was measured soon after application of DMSO in the same 
cells and the results were similar to those found in Fig 4, indicating that it is 
distinguishable from that of DMSO. The dwell times could be categorized into short 
(Amiodarone and Loxapine), long (Minoxidil and Furosemide) and very long 
(Dofetilide). Time constants and amplitude were also calculated for MCF7 cells 
(Supplemental Figure 6). 
 
Control of drug induced [Ca2+]i by extracellular calcium 
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In the majority of our live calcium imaging experiments, we used nominally calcium 
free extracellular solution to investigate [Ca2+]i release, the external calcium was 
estimated to exceed 70 µM due to impurity contamination from other salts. The 
measured Ca2+ in the extracellular solution, in so-called Ca2+ free solutions, was 
found to be 62.3 ± 8.2 µM (n=30 from 3 batches).  
It is known that in certain circumstances [Ca2+]i release can be triggered by entry of 
very small amounts of Ca2+ from outside, via the opening of calcium channels, to 
initiate a much larger increase of free [Ca2+]i by a mechanism termed calcium 
induced calcium release (CICR) (Bootman et al., 2002). CICR has been described in 
many cell types including striated muscle (Endo et al., 1970; Fabiato, 1983; Endo, 
2007) and non-muscle cells (Verkhratsky and Shmigol, 1996). Even entry from sub-
micro-molar levels of extracellular calcium can be sufficient to activate CICR 
pathways (Berridge et al., 2003; Endo, 2009).  
We therefore hypothesized that at least one pathway through which the present 
drugs activated intracellular stores was via CICR. To test this hypothesis we reduced 
free calcium in the extracellular solution with 5mM EGTA (ethylene glycol tetra-acetic 
acid). The resulting calculated level of calcium was then less than <10 nM. The 
amplitude of [Ca2+]i signal in the presence of EGTA was significantly reduced in most 
of our compounds (Fig. 8). These results indicate that a CICR mechanism may be 
operating to activate intracellular Ca2+ stores in response to the application of drugs. 
Live calcium imaging was also performed on PC3 cells, pretreated with calcium 
channel blocker Nifedipine prior to addition of compound Minoxidil or Loxapine. The 
drug induced [Ca2+]i release was inhibited by Nifedipine (Supplemental Figure 7).  
The results are similar to those observed when EGTA was added to the extracellular 
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solution, further indicating that the drug induced [Ca2+]i release is facilitated by 
extracellular calcium.  
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Discussion 
In this study, we demonstrate that Amiodarone, Dofetilide, Furosemide, Minoxidil, 
Loxapine and Nicorandil (see Supplemental Figure 8 for the molecular structures of 
the compounds) give rise to a [Ca2+]i signal in PC3 prostate cancer cell lines and in 
MCF7 breast cancer cell lines. To our knowledge this is the first report of these 
compounds acting on [Ca2+]i in cancer cells.  
Amiodarone, a benzofuran derivative, a class III anti-arrythmic and a K+ channel 
blocker has been used to treat tachycardias (Kodama et al., 1997); it is known to 
induce intracellular calcium alterations in fungi (Sen Gupta et al., 2003; Courchesne 
et al., 2009). Dofetilide, another antiarrhythmic, selectively inhibits the rapid 
component of hERG/IKr K+ current (Rasmussen et al., 1992). Furosemide, a 
sulfamoylanthranilic acid derivative and diuretic inhibits Na-K-Cl co-transporter 
(Haas, 1989). Both Nicroandil and Minoxidil act on adenosine triphosphate sensitive 
K+ (KATP) channels (Taira, 1989; Edwards and Weston, 1990) and are used as 
vasodilators; Minoxidil is further used  to stimulate hair growth and induces 
intracellular calcium release in dermal papilla cells (Li et al., 2001). Loxapine, an 
antipsychotic drug, activates Slack channels (Biton et al., 2012) and inhibits 
mechanosensitive ion channels (e.g.KCNK2) (Thummler et al., 2007b) (see 
Supplemental Table 1).  
 
The role of calcium in cell proliferation and apoptosis in both cancer and immune 
cells (Schwarz et al., 2013), indicates that modulation of intracellular calcium 
processes may present a potential therapeutic action of the compounds used in this 
study and would be a useful tool in cancer research.  
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Since the measured signal was sensitive to the external level of free calcium we 
propose that a novel mechanism for [Ca2+]i release by Amiodarone, Furosemide, 
Minoxidil and Loxapine is a CICR facilitated mechanism as evidenced by the live 
calcium imaging results (Fig  8). The compounds tested have a variety of clinical 
applications, including vasodilation, antiarrhythmics and diuretics. They exert their 
therapeutic actions by interacting mainly with potassium channels and other ion 
transporters. The current literature describes a number of receptor interactions for 
each compound individually but fails to make any connection with any [Ca2+]i release 
(Edwards and Weston, 1990; Nattel et al., 1992; Rasmussen et al., 1992; Yamada et 
al., 1997; Lee et al., 2007; Biton et al., 2012). A general feature of calcium signalling 
is how different calcium signals can be translated into specific cell functions 
depending on their amplitude and duration; the type of signal may result in different 
functions such as proliferation, apoptosis and tolerance (Bandyopadhyay et al., 
2007; Qui et al., 2011). 
The electropharmacology of the compounds tested, indicates that there is an 
inhibition of currents evoked at both negative and positive potentials (Fig 1 and Fig 
2). Most of these compounds have been investigated for their electrophysiological 
properties either in cells over-expressing ion channels (Yamada et al., 1997; 
Thummler et al., 2007b) or in neurons and cardiac cells (Leblanc et al., 1989; 
Rasmussen et al., 1992; Satoh, 1993; Kodama et al., 1997; Desai et al., 2000; 
Thummler et al., 2007b; Biton et al., 2012). Very little is known about how these 
drugs influence electrical properties of the cell membrane in prostate or other cancer 
cell lines. Our primary motivation in investigating the electrophysiological properties 
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of the modulation of whole cell currents by high throughput approach was to set a 
baseline and identify a range of concentrations for [Ca2+]i assays in PC3 cells.  
Intracellular cytosolic calcium concentration levels can increase from a variety of 
routes. Most routes involve membrane bound ion channel transporters, which 
promote calcium influx. A key observation in our study is that the [Ca2+]i rise induced 
by the compounds tested here must be via release from internal stores via CICR 
once calcium enters the cell (Fig 9) as chelation of external calcium significantly 
reduces the response (between 60-100%). Routes for calcium entry via the 
membrane include specific calcium channels as well as through non-specific cation 
channels which have significant calcium permeability. Such channels include 
members of the TRP family, some of which are known to be expressed in cancer cell 
lines (Nilius and Owsianik, 2010).  
An estimate of the flux through such channels can be obtained from the I-V curves of 
Figure 1. Although there is little sign of the potential dependence expected for a 
voltage-gated calcium channel, the inward currents measured at -100 mV in control 
cells suggest typical standing conductance of 2.7 nS (n=15). This is equivalent to a 
cell input resistance of 380 Mohm, and the presence of about 100 cation-permeable 
TRP channels. Depending on the cell volume around the calcium stores into which 
external Ca2+ would flow, it is plausible that even such a number of calcium entry 
sites could lead to the CICR signal observed. However, it is also plausible, 
comparing the live calcium imaging and electrophysiology data (Fig 8 and Fig 1, 
respectively) that there may be an independent inhibition of the whole cell currents 
by the compounds tested as well as an interdependent CICR mediated mechanism 
of [Ca2+]i.  
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Other possible contributory routes are the ones involving membrane bound receptors 
which act on [Ca2+]i intracellular stores with the help of secondary messengers. The 
main calcium store in most non-striated cells is the endoplasmic reticulum. The 
major calcium flux channels located on the endoplasmic reticulum are the ryanodine 
receptors (RyRs) (Otsu et al., 1990) and inositol 1,4,5-triphosphate receptors (IP3Rs) 
(Nixon et al., 1994). Calcium is also stored in the mitochondria, sarcoplasmic 
reticulum (muscle cells only) and nuclear envelop and they also have to be taken 
into consideration as a possible source of the Ca2+ signal observed. Calcium 
mobilization from intracellular stores has been known to occur due to elevation of 
inositol triphosphate (IP3) levels via the IP3/DAG pathway (Nakamura et al., 2000; 
Berridge, 2012). G protein-coupled receptors activate phospholipase C, which in turn 
hydrolyses PIP2 to form IP3 and DAG (diacyglycerol). IP3 then binds to the IP3 
receptor (a calcium channel) on the endoplasmic reticulum, releasing calcium into 
the cytoplasm. Amiodarone has been shown to be a direct activator of G protein-
coupled receptor; thus, this is a plausible route of the signal induced by this 
compound, resulting in calcium release.  
There is little evidence in the literature to suggest that the other compounds used in 
this study are linked with activation of G protein-coupled receptors. There are a large 
number of G protein-coupled receptors (Gαq, Gα11, Gα14, Gα15, Gβγ) and protein 
tyrosine kinase receptors that are coupled to different phospholipase C isoforms 
(PLCβ1-4, PLCγ1-2, PLCδ1-4, PLCε) which are able to generate [Ca2+]i mobilization 
through IP3 (Berridge, 2012). Duration, intensity and type of calcium flux seen in 
different cell types may regulate different Ca2+ dependent cellular functions, such as 
proliferation and motility (Berridge et al., 2000). For example, studies in T-cells, show 
different Ca2+ signals can be translated into specific transcription factor profiles 
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which may cause the cell to undergo apoptosis, to proliferate or increase their 
tolerance to environmental stress (Macian et al., 2002; Bandyopadhyay et al., 2007; 
Qui et al., 2011). The focus of our future studies will be to examine what effects 
these compounds have on the transcriptional profile of cancer cells and pinpoint the 
receptors and downstream pathways responsible for the Ca2+ flux we have observed 
in this study, with the aim of creating a set of biological tools for manipulating 
intracellular calcium dynamics to selectively control cell proliferation or cell death. 
In summary, we have shown for the first time that exposure to various ion channel 
activity regulators causes a release of [Ca2+]i with distinct characteristics of rise, 
dwell and fall time constants. We further show that a possible mechanism for the 
drug induced [Ca2+]i release is via CICR (Fig 9). We believe that the data presented 
here shows a novel cellular function for these known ion channel regulators and may 
have implications on the actions and side effects of these drugs that have been in 
clinical use for some time. 
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Figure Legends 
Figure 1. A representative current voltage (I-V) curve of 3-6 independent cells is 
shown. Single cells were placed in a QPatch plate (see Materials and Methods) and 
recorded in a whole cell configuration. A voltage ramp of -120 to +120mV was 
executed every 3 seconds. Current voltage characteristics of control (grey lines) and 
with drugs (colored lines). (A) Loxapine (orange) at 33µM (B) Dofetilide (blue) at 
50µM (C) Nicorandil (green) at 50µM and (D) Minoxidil (red) at 50µM (similar 
experiments were performed for Amiodarone and Furosemide, not shown).  All 
compounds tested inhibited the whole cell current at negative and positive potentials 
by 25-70% of the control. 
Figure 2. Concentration dependence of the inhibition of endogenous currents using 
QPatch in PC3 cells by compounds used in this study. A voltage ramp was 
employed to measure currents in PC3 cells using the QPatch system (see Materials 
and Methods). Peak currents with and without the compounds at 120mV were used 
to construct concentration dependence of the inhibition of the currents. Each graph 
represents a single cell; IC50s were calculated using the data represented above. X- 
axis for each compound is found below each condition’s graphs as a scale bar (µM). 
Figure 3. Snapshots of PC3 cells labelled with calcium indicators Fluo-4 (green) and 
FuraRed (red), of four time points (A-D) at t = 0, 281, 288 and 492 seconds. At t = 0s 
(A), steady state, base-line; t = 281s (B) approximately 50% of cells undergoing a 
calcium release; t = 288s (C) calcium signal during the peak of the response; t = 
492s (D) after the calcium response has ended the signal returns to baseline. The 
diffusion constant has been previously measured as 0.21µm/s. Scale bar = 10μm. 
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Figure 4. Representative traces of intracellular calcium release in PC3 cells in 
response to addition of 50μM concentration of compounds (green, Amiodarone; 
orange, Minoxidil; red, Loxapine; pink, Furosemide; gray, Dofetilide; blue, Nicorandil; 
black, Dimethyl sulfoxide (DMSO). The y axis is the ratio of Fluo-4/FuraRed 
channels (unbound calcium/bound calcium respectively) in arbitrary units (A.U). The 
mean amplitude and time constants of each compound were used to select a 
representative trace with similar characteristics. Number of independent experiments 
n=5-8 per compound. 30-80 single cell measurements per compound. 
Figure 5. Concentration dependence of the intracellular calcium release using live 
calcium imaging.  Box plots of Loxapine, Minoxidil and Furosemide. The x axis is 
concentration (µM) and the y axis is the amplitude of the waveforms in arbitrary units 
(A.U). 
Figure 6. Box plots for amplitude of the calcium waveform. Amplitude measurements 
at the peak of the response on the addition of each compound (50μM) to PC3 cells 
(n = 30-78 cells per compound). Statistical significance was calculated using a 
Mann-Whitney U test. The amplitude is measured in Arbitrary Units (A.U). Number of 
independent experiments n=5-8 per compound; 30-80 single cell measurements per 
compound. 
Figure 7. Box plots for time constants of the calcium waveform. The time constants 
(A, rise; B, dwell; and C, fall times) were calculated from calcium waveform 
generated by the addition of each compound (50 μM) to PC3 cells. Minoxidil (Min), 
Amiodarone (Ami), Nicorandil (Ncc), Dofetilide (Ddf), Loxapine (Lox), Furosemide 
(Fur) labels indicated.  A principal component analysis was performed on the dwell 
time constants and a Loading plot (D) is shown. On the basis of this 3 components 
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are identified with a majority of drugs segregate into two components. For A, B, C 
the number of independent experiments is n=5-8 per compound. 30-80 single cell 
measurements per compound. 
Figure 8. Effect of reducing extracellular calcium with EGTA. When EGTA reduced 
the external calcium to <10 nM  (in PBS), the response was reduced. Control 
solution, PBS; [Ca2+] = 62.3µM ± 8.2). y-axis amplitude in arbitrary units (AU). 
Number of independent experiments per compound: n=3-4. 55-205 single cell 
measurements per compound. 
Figure 9. A model for drug induced [Ca2+]i release via a CICR mechanism. We 
propose that binding of compounds such as Amiodarone (shown), Furosemide, 
Loxapine and Minoxidil bind to membrane protein receptors initiate activation of Ca2+ 
channel. Entry of external Ca2+ (dark green) into the cell depolarizes the cell 
electrical potential that activates intracellular Ca2+ (light green) stores (e.g. in the 
endoplasmic reticulum). This activates release of [Ca2+]i from the stores; Ca2+ 
release in the cytosol in response to the drugs can be seen in Fig. 3 and 
Supplemental movies. The free cytosolic Ca2+ then enters the nucleus.  
 









